U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357610) titled 'An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants' on Jan. 02.
Brief Summary: This study is an open-label, fixed-sequence, two-period Phase 1 clinical trial in healthy adult Chinese participants with a total of 3 cohorts, 16-20 healthy adult Chinese participants are planned to be enrolled in each cohort.
Study Start Date: Jan. 05
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Intervention:
DRUG: SIM0270
oral
DRUG: itraconazole
oral
DRUG: Rifampin
oral
DRUG: midazolam
oral
Recruitment Status: RECRUITING
Sponsor...